Congruent microbiome signatures in fibrosis-prone autoimmune diseases: IgG4-related disease and systemic sclerosis - Plichta, Damian R.; Somani, Juhi; Pichaud, Matthieu; Wallace, Zachary S.; Fernandes, Ana D.; Perugino, Cory A.; Lähdesmäki, Harri; Stone, John H.; Vlamakis, Hera; Chung, Daniel C.; Khanna, Dinesh; Pillai, Shiv; et al. (Genome medicine, 2021)
Keywords: Analysis; Antibiotics; Antigens; Arthritis; Autoimmune diseases; Autoimmunity; B cells; Bacteroidetes - physiology; Care and treatment; Case-Control Studies; CD4 antigen; Clostridium; Cohort Studies; Colonization; Connective tissue; Cytotoxicity; Deoxyribonucleic acid; Development and progression; Digestive system; Disease; DNA; DNA sequencing; Extracellular matrix; Extracellular Matrix - metabolism; Fibronectin; Fibronectin-binding protein; Fibronectins; Fibrosis; Firmicutes - physiology; Gastrointestinal diseases; Gastrointestinal Microbiome; Gene set enrichment analysis; Genes; Genetic testing; Gut microbiome; Helper cells; Homocysteine; Humans; Hydroxyproline; IgG4-RD; Immune system; Immunoglobulin G; Immunoglobulin G4; Immunoglobulin G4-Related Disease - microbiology; Immunoglobulins; Inflammation; Inflammatory bowel diseases; Intestinal microflora; Intestine; Lymphocytes; Lymphocytes T; Metagenomics; Mevalonate pathway; Mevalonic acid; Microbiomes; Microbiota; Mucosa; Multiple sclerosis; Pathogenesis; Patients; Protein binding; Proteins; Rare diseases; Rheumatoid arthritis; Rheumatoid factor; Scleroderma; Scleroderma (Disease); Scleroderma, Systemic - microbiology; Signal Transduction; Species; Species Specificity; Systemic scleroderma; Systemic sclerosis; T cells; Autoimmunity; Gut microbiome; Systemic sclerosis; IgG4-RD